# Bioventus Inc.: Form 8-K, filed Aug 5, 2026

- Company: [Bioventus Inc.](/companies/bvs.md) (CIK 1665988)
- Form: 8-K
- Filed: 2026-08-05
- Accepted by EDGAR: Aug 5, 2026, 07:40 ET
- Period: 2026-08-05
- Accession: 0001665988-26-000041
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1665988/000166598826000041/bvs-20260805.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1665988/000166598826000041/

## Items reported

- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1665988/000166598826000041/bvs-20260805.htm

Filed Aug 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001665988-26-000041. Last ingested by Listed: Oct 27, 2026, 17:28 ET. No prices; not investment advice.